Related Experiment Videos
Failure of intraarticular ceftazidime in a patient with Pseudomonas aeruginosa septic arthritis
E A Kay1, P S Klimiuk, G Ronson
1Department of Pharmacy, University of Manchester, Salford, England.
Abstract:
This report describes a patient with Pseudomonas aeruginosa septic arthritis who received ceftazidime by the intravenous and intraarticular routes. Concentrations of ceftazidime in the synovial fluid following both routes of administration were measured and found to be above the minimum inhibitory concentration. Despite this the organism was not eradicated. We were unable to find other literature describing the disposition of ceftazidime in synovial fluid and therefore this single-patient study provides novel information. We were unable to account for the apparent failure of therapy.
Insights
This study investigated ceftazidime levels in synovial fluid for Pseudomonas aeruginosa septic arthritis. Despite concentrations exceeding the minimum inhibitory concentration, the infection persisted, highlighting a potential treatment challenge.
Area of Science:
- Pharmacokinetics and Pharmacodynamics
- Infectious Diseases
- Rheumatology
Background:
- Septic arthritis caused by Pseudomonas aeruginosa is a serious condition.
- Ceftazidime is a commonly used antibiotic for Pseudomonas infections.
- Optimal dosing strategies for intraarticular infections require further investigation.
Observation:
- A single patient with Pseudomonas aeruginosa septic arthritis was treated with intravenous and intraarticular ceftazidime.
- Synovial fluid ceftazidime concentrations were measured after administration via both routes.
- Measured concentrations were above the minimum inhibitory concentration for Pseudomonas aeruginosa.
Findings:
- Despite achieving supra-therapeutic levels in synovial fluid, ceftazidime failed to eradicate Pseudomonas aeruginosa.
- This case provides novel, albeit limited, data on ceftazidime disposition in synovial fluid.
- The mechanism for the apparent therapeutic failure remains unexplained.
Implications:
- This case suggests that high synovial fluid concentrations of ceftazidime may not guarantee treatment success in septic arthritis.
- Further research is needed to understand factors influencing antibiotic efficacy in septic joints.
- Clinical guidelines may need to consider alternative or adjunctive therapies for complex cases.